Drdgold (DRDGF) Common Equity (2017 - 2022)

Drdgold has disclosed Common Equity across 6 years of filings, most recently posting $351.0 million for Q2 2022.

• Common Equity for Q2 2022 came in at $351.0 million, up 2.97% year-over-year; the trailing twelve-month figure through Jun 2022 was $351.0 million (up 2.97% YoY), and the FY2022 annual result was $351.0 million, up 2.97% from the prior year.
• Common Equity came in at $351.0 million for Q2 2022 at Drdgold, up from $340.9 million in the prior quarter.
• In the past five years, Common Equity ranged from a high of $351.0 million in Q2 2022 to a low of $100.7 million in Q2 2018.
• The 5-year median for Common Equity is $225.6 million (2020), against an average of $241.1 million.
• Across the five-year window, Common Equity grew 1.98% in 2018 and surged 85.72% in 2019, its largest moves.
• Drdgold's Common Equity stood at $100.7 million in 2018, then soared by 85.72% to $187.1 million in 2019, then climbed by 20.59% to $225.6 million in 2020, then soared by 51.08% to $340.9 million in 2021, then advanced by 2.97% to $351.0 million in 2022.
• The last three Common Equity figures came in at $351.0 million (Q2 2022), $340.9 million (Q2 2021), and $225.6 million (Q2 2020), per Business Quant data.